Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study.
Lancet Haematol. 2023 Nov;10(11):e902-e912. doi: 10.1016/S2352-3026(23)00207-7.
Lancet Haematol. 2023.
PMID: 37914483
Clinical Trial.
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia.
Boyiadzis M, Desai P, Daskalakis N, Donnellan W, Ferrante L, Goldberg JD, Grunwald MR, Guttke C, Li X, Perez-Simon JA, Salamero O, Tucker T, Xu X, Yang J, Pemmaraju N, Alonso-Dominguez JM.
Boyiadzis M, et al. Among authors: guttke c.
Clin Transl Sci. 2023 Mar;16(3):429-435. doi: 10.1111/cts.13467. Epub 2023 Jan 16.
Clin Transl Sci. 2023.
PMID: 36564917
Free PMC article.
Item in Clipboard
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
Narayan R, Piérola AA, Donnellan WB, Yordi AM, Abdul-Hay M, Platzbecker U, Subklewe M, Kadia TM, Alonso-Domínguez JM, McCloskey J, Bradford K, Curtis M, Daskalakis N, Guttke C, Safer K, Hiebert B, Murphy J, Li X, Duchin K, Esteban D.
Narayan R, et al. Among authors: guttke c.
Clin Transl Sci. 2024 Mar;17(3):e13742. doi: 10.1111/cts.13742.
Clin Transl Sci. 2024.
PMID: 38494922
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite